Welke invasieve controlemethoden worden gebruikt tijdens de behandeling van ernstige bètablokkertoxiciteit?

auteur

Adhi Sharma, MD Medical Toxicology Consultant,New York City Poison Control Center
Adhi Sharma, MD is lid van de volgende medische verenigingen: American Academy of Clinical Toxicology, American College Of Emergency Physicians, American College of Medical Toxicology
Disclosure: Nothing to disclosure.

coauteur(s)

Lemeneh Tefera, MD, Faaem Attending Physician, Department of Emergency Medicine, Beth Israel Medical Center
Lemeneh Tefera, MD, FAAEM is een lid van de volgende medische verenigingen: American Academy of Emergency Medicine
Disclosure: Nothing to disclosure.Aman Aminzay, MD Attending Physician, Department of Emergency Medicine, Beth Israel Medical Center, Albert Einstein College Of Medicine
Aman Aminzay, MD is een lid van de volgende medische verenigingen: American College Of Emergency Physicians
Disclosure: Nothing to disclosure.Gil Z Shlamovitz, MD, FACEP Associate Professor of Clinical Emergency Medicine, Keck School Of Medicine of The University of Southern California; Chief Medical Information Officer, Keck Medicine of USC
Gil Z Shlamovitz, MD, FACEP is een lid van de volgende medische verenigingen: American College Of Emergency Physicians, American Medical Informatics Association
Disclosure: Nothing to disclosure.Asim Tarabar, MD Assistant Professor, Director, Medical Toxicology, Department of Emergency Medicine, Yale University School Of Medicine; Consulting Staff, Department of Emergency Medicine, Yale-New Haven Hospital
Disclosure: Nothing to disclosure.

Dankbetuigingen

Geef een antwoord

Het e-mailadres wordt niet gepubliceerd.